Clinical Trials Browser

Phase 3 × Adenocarcinoma × GV1001 peptide × Clear all

NCT00358566 2008-05-19

GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer

Phase 3 Terminated

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms